001-HIV AIDS 2015

8/9/2019 001-HIV AIDS 2015

1/54

HIV/AIDS AND THEWORKPLACE

RICARDO T. BALAGOT, MD, FPCOM

8/9/2019 001-HIV AIDS 2015

2/54

HIV AND AIDS

SESSION OBJECTIVES:

• General: To generate awareness andappreciation of the problem of IV!"I#S and itsimpact on the wor$place%

• Spe!":

& describe and e'plain IV!"I#S as an illness(

its nat)re* detection* and pre+ention(& recogni,e IV!"I#S as a wor$place iss)e(

& form)late re-entr. plans on wor$place policiesand programs on IV and "I#S%

8/9/2019 001-HIV AIDS 2015

3/54

CO#RSE O#TLINE:

I% Sit)ationer

II% Basic Information on IV and "I#S

III% /ep)blic "ct 0123 and the National4or$place 5olic.

IV% Inter+entions and /esponse

HIV AND AIDS

8/9/2019 001-HIV AIDS 2015

4/54

HIV & AIDS:The Global Pandemic

Over 15,000 men, women, and childrenare infected with HIV each day (or oneperson per second).

Half of all people who acqire HIV !ecomeinfected !efore the a"e of #5, and most die!efore the a"e of $5.

In #00%, an estimated 11.% million yon"people a"ed 15' live with HIV and I*worldwide.

8/9/2019 001-HIV AIDS 2015

5/54

+5 of people with HIV and I* live in thedevelopin" contries, sally from the poor,ethnic minority "rops, or poplations thatare socially mar"inali-ed.

orldwide, women accont for 50 ofadlts livin" with HIV.

/ore than half of those newly infected withHIV are !etween the a"es of 15 and #'years old.


8/9/2019 001-HIV AIDS 2015

6/54

/ore than #5 million people have died of

I* since 1+%1.

In developin" and transitional contries, +.5million are in immediate need of life savin"

I* medicines, only ' million ('#) are

receivin" the dr"s.


8/9/2019 001-HIV AIDS 2015

7/54

8/9/2019 001-HIV AIDS 2015

8/54

HIV & AIDS:Global Estimates, 200'

Estimate

Rane

$oth Ameica ()* million ()2 + 2)0 million

esten and -ental E!o.e 820,000 /20,000 '20 ,000

Easten E!o.e cental Asia ()1 million () + ()* million

East Asia //0,000 *30,000 ()0 million4iddle East and $oth A5ica 130,000 100,000 *0,000

-aibbean 210,000 220,000 2/0,000

So!th and So!th East Asia 1)( million )/ + 1)3 million

S!bSahaan A5ica

-ental and So!th A5ica6ceania

T6TA7

Deaths d!e to Aids

22)* million()1 million*/,000

) million()8 million

20)' + 21)2 million()2 + ()3 million*0,000 + 31,000

()1 + *) million

()3 + 2)( million

8/9/2019 001-HIV AIDS 2015

9/54

N $ % & e r ' ( C a )

e )

*orce hilippine HIV 6 I* 7e"istry

2 "eas

(0 "eas

3

"eas1"eas

( "ea

HIV & AIDS:The Phili..ine Scenaio

#o)bling Time of IV and "I#S cases

8/9/2019 001-HIV AIDS 2015

10/54

8/9/2019 001-HIV AIDS 2015

11/54

Demoa.hic Data Dec 200' an + Dec 200' -!m!lati%e Data('81 + 200'

8otal 7eported 3ases 1#4 %$5 ','#'

symptomatic 3ases 1#$ %04 $,5+#

I* 3ases $ #+ %$#/ales 1#1 2$# $,#$#9

:emales 5 10$ 1,1%19

;oth 15' yo $% #1% 2#'

3hildren

8/9/2019 001-HIV AIDS 2015

12/54

Demoa.hic Data Dec 200' an 20(0 -!m!lati%e Data('81 + 200'

8otal 7eported 3ases 1#4 1'$ ',542

symptomatic 3ases 1#$ 1'1 $,2$$

I* 3ases $ # %$'/ales 1#1 1#5 $,$529

:emales 5 1% 1,1++9

;oth 15' yo $% '2 221

3hildren

8/9/2019 001-HIV AIDS 2015

13/54

8/9/2019 001-HIV AIDS 2015

14/54

HIV & AIDS

8/9/2019 001-HIV AIDS 2015

15/54

Demoa.hic Data A!) 20(( an + A!) 20(( -!m!lati%e Data('81 + 20((

8otal 7eported 3ases 1+4 1,'14 2,'1$

symptomatic 3ases 1%+ 1,$50 4,501

I* 3ases 2 44 +$0/ales 1%# 1,$0+ 4,004

:emales 1' 102 1,'1'

;oth 15' yo 54 '1$ 1,4#2

3hildren

8/9/2019 001-HIV AIDS 2015

16/54

HIV & AIDS:The Phili..ine Scenaio

8/9/2019 001-HIV AIDS 2015

17/54

A Ac;!ied

I Imm!ne

D De5icienc"

S S"ndome

C serios and sally fatal conditionin which the !odyDs immne

system is severely weaBened and

cannot fi"ht off infection.

H H!man

I Imm!node5icienc"

V Vi!s virs which cases I*

HIV AND AIDS

8/9/2019 001-HIV AIDS 2015

18/54

CPeople with HIV DO NOT meanthey have AIDS.

C HIV remains dormant in the !ody

for several years !efore some

nBnown factors tri""er the

infections associated with I*

C/edian inc!ation period for adlt

can !e as lon" as 10 years.

Crin" this period, the people with

HIV may looB healthy and !ein"

naware of their infection stats.

HIV AND AIDS

8/9/2019 001-HIV AIDS 2015

19/54

hat is HIV in5ection<

A li5etime in5ection

$o %accine to .e%ent it

$o c!e $o sins and s"m.toms

Desto"s the imm!ne s"stem

-an be detected =ith HIVantibod" test

Vi!s does not li%e lon o!tside the bod"

8/9/2019 001-HIV AIDS 2015

20/54

hat is AIDS<

A condition =hee sins and s"m.tomsa..ea as a es!lt o5 %aio!s

o..ot!nistic in5ections7i5e theatenin

HIV ca!ses AIDS

H d ith

8/9/2019 001-HIV AIDS 2015

21/54

Ho= does a .eson =ithHIV loo> li>e<

??? @o! cant tell i5 a.eson has HIV b"meel" loo>in at

himBhe)

8/9/2019 001-HIV AIDS 2015

22/54

3' cell helps s to fi"ht a"ainst varios infections

Ho= HIV in5ects <

3'

8/9/2019 001-HIV AIDS 2015

23/54

HIV attacBs 3' cell, mltiply inside and "radally Bills them.

Once 3' are destroyed or !odyDs resistance to fi"ht infections

"oes down and person sffers from lots of infections

HIVIDs

Ho= HIV in5ects

8/9/2019 001-HIV AIDS 2015

24/54

8/9/2019 001-HIV AIDS 2015

25/54

8/9/2019 001-HIV AIDS 2015

26/54

HIV is $6T tansmitted

C thro"h casal contact in any settin"E schools, worBplace,or social settin"s.

C thro"h shaBin" hands, h""in", or a casal Biss.

C thro"h insect, food, water, clothes, toilets, swimmin"

pools, and drinBin" and eatin" tensils.

D t ti 5 HIV

8/9/2019 001-HIV AIDS 2015

27/54

Detection o5 HIVAntibod"

C 8he HIV anti!ody test

E etects HIV anti!odies in the !lood, not HIV

E nti!odies develop $&1# weeBs to 4 months

after infection

E FI=O G7IO E anti!odies cannot !e

detected in !lood, !t patient infective drin"this period

8/9/2019 001-HIV AIDS 2015

28/54

HIV antibod" Test Res!lts

POSITIVE HIV-antibody

C etection of anti!odies in the !lood indicates that infection

has occrred

C 8he person can infect others

C positive HIV&anti!ody test reslt does not mean that aperson has I*

NEGATIVE HIV-antibody

C HIV anti!odies were not detected in the personDs !loodC /ay indicate that the person is not infected O7

C 8he person may !e infected !t has not prodced detecta!le

qantities of HIV anti!odies

Pe%ention o5 HIV

8/9/2019 001-HIV AIDS 2015

29/54

Pe%ention o5 HIVIn5ection

RE4E4CER AC-DE?

A!stinence

Ce :aithfl-orrect andconsistent condomse

Do not se r"sEdcation

8/9/2019 001-HIV AIDS 2015

30/54

4edical Teatment

C 8oday there are medical treatments that

can slow down the rate at which HIV

weaBens the immne system.C 8here are other treatments that can

prevent or cre some of the illnesses

associated with I*.

Na*!'nal

8/9/2019 001-HIV AIDS 2015

31/54

G'al) '( DOLE Na*!'nal W'r+plaeG'al) '( DOLE Na*!'nal W'r+plae

P'l!P'l!

Pre-en*!'n an 'n*r'l '(

HIV/AIDS

Pr'*e*!'n '( 'r+er)0 r!12*) 3

!1n!*

Re'1n!*!'n '( !n!-!$al

re)p'n)!&!l!*

Pr'-!)!'n '( &ene"*) !n 2!124r!)+

)e**!n1)

E)*a&l!)2%en* '( Sere*ar!a*

O&5e*!-e) '( *2e ILO C'e

Pre-en* )prea '( HIV

C'%&a* )*!1%a 3

!)r!%!na*!'n M!*!1a*e *2e !%pa* '(HIV/AIDS

Pr'-!e are 3 )$pp'r*

Ra*!'nale '( RA 6789

Pre-en*!'n an 'n*r'l '( HIV/AIDS Pr'*e*!'n '( r!12*) an !1n!* '( PLWHA

Re'1n!*!'n '( r'le '( PLWHA !n pre-en*!'n an'n*r'l

Pr'-!)!'n '( 'n*r'l %ea)$re) !n 2!124r!)+)e**!n1)

Na*!'nalRe)p'n)e

8/9/2019 001-HIV AIDS 2015

32/54

The Phili..ine HIV

and AIDS Pe%entionand -ontol Act o5

(''8

REP#C7I- A-T 8*01

/" 0123 enacted on 6ebr)ar.78* 7990I// was prom)lgated on "pril

78* 7999

8/9/2019 001-HIV AIDS 2015

33/54

roml"ates policies and prescri!es measres

Instittes a nationwide HIV and I* information

and edcation pro"ram Gsta!lishes a comprehensive HIV and I*

monitorin" system

*tren"thens the hilippine =ational I*

3oncil

REP#C7I- A-T 8*01

8/9/2019 001-HIV AIDS 2015

34/54

Pr'-!)!'n) Rele-an* *' *2eW'r+plae

Ar*!le I : E$a*!'n an In('r%a*!'n

"rticle II : Safe 5ractices and 5roced)res

Ar*!le III : Te)*!n1, Sreen!n1 3

C'$n)el!n1

"rticle IV : ealth and S)pport Ser+ices

"rticle V : onitoringAr*!le VI : C'n"en*!al!*

Ar*!le VII : D!)r!%!na*'r A*) an

p'l!!e)

"rticle VIII : The 5hilippine National "I#S

REP#C7I- A-T 8*01

8/9/2019 001-HIV AIDS 2015

35/54

(Section 6. HIV/AIDS In('r%a*!'n !n *2e W'r+plae Ar*!le I. ED#CATION 3Ar*!le I. ED#CATION 3INFORMATIONINFORMATION

All 1'-ern%en* an pr!-a*e e%pl'ee) )2all &epr'-!e !*2 )*anar!;e &a)! !n('r%a*!'n an!n)*r$*!'n 'n HIV/AIDS< S2all &e !n*e1ra*e !n*' 'r!en*a*!'n, *ra!n!n1,'n*!n$!n1 e$a*!'n, HR e-0* pr'1ra%), e*.

Ea2 e%pl'er )2all e-el'p, !%ple%en*, e-al$a*e an($n a 'r+plae HIV/AIDS e$a*!'n an !n('r%a*!'npr'1ra%.

In 'lla&'ra*!'n !*2 *2e DOH, DOLE )2all '-er)ee *2e

an*!4HIV/AIDS a%pa!1n !n all pr!-a*e '%pan!e)<

REP#C7I- A-T 8*01

8/9/2019 001-HIV AIDS 2015

36/54

8/9/2019 001-HIV AIDS 2015

37/54

All 2eal*2 pr'(e))!'nal), %e!al!n)*r$*'r), 'r+er), e%pl'er),rer$!*%en* a1en!e), !n)$rane '%pan!e),a*a en'er), an '*2er $)*'!an) '( an

%e!al re'r) / *e)* re)$l*) *' '&)er-e)*r!* 'n"en*!al!* par*!$larl *2e!en*!* an )*a*$) '( per)'n) !*2 HIV.

Ar*!le VI:CONFIDENTIALIT= Section 0) 4edical -on5identialit"Section 0) 4edical -on5identialit"

REP#C7I- A-T 8*01

8/9/2019 001-HIV AIDS 2015

38/54

D!)r!%!na*!'n !n an ('r% (r'% pre4*' p')*4e%pl'%en*, !nl$!n1 2!r!n1,pr'%'*!'n 'r a))!1n%en*, &a)e 'n *2ea*$al, pere!-e 'r)$)pe*e HIV )*a*$) '( an !n!-!$al !)

pr'2!&!*e.

Ter%!na*!'n (r'% 'r+ 'n *2e )'le&a)!) '( a*$al, pere!-e 'r )$)pe*eHIV )*a*$) !) ee%e $nla($l%

Ar*!le VII. DISCRIMINATION ACTS 3POLICIESSection *) Discimination in the o>.laceSection *) Discimination in the o>.lace

REP#C7I- A-T 8*01

8/9/2019 001-HIV AIDS 2015

39/54

HIVBAIDS and the

o>.lace

8/9/2019 001-HIV AIDS 2015

40/54

h" C!siness Sho!ld -ae

It is mandated !y law

It will contri!te to the attainment of the /

It is "ood for the contry

It impacts !siness

8/9/2019 001-HIV AIDS 2015

41/54

C *ti"ma and iscriminationC 8ension amon" worBers

C ender ineqalities

C ressre on health 6 social secrity systems

C 8hreatened occpational safety and health!enefits of worBers

Im.act in the o>.lace

8/9/2019 001-HIV AIDS 2015

42/54

ReducedProductivity

(assume 50%)/yr

Care &

Maintenance/yr

Exit Costs (OneTime)

Medical

Redundancy

or

Death

+

Lost Training

+

Recruitment

TOTAL

Sr. Leadersi!

Mana"eria#

&Su!ervisory

$ 4!000

$ "0!000

#40!000

50!000

0!000

"0!000

$ %'*'+'''

Su!!ort Sta,,

$ "!000

$ "0!000

5!000

5"!000

!000

4!000

$ -+'''

$ &!000

$ "0!000

"4!000

#!000

#!000

"!000

$ 00+'''

R!nnin -osto5 Poamme:

*0 Bem.lo"eeB"

Vs)

The Business Case for

an HIV and AIDS in the

Workplace Program

(ased on the

Shell e!perience"

Im.act in the o>.lace

4hat can be done in the

8/9/2019 001-HIV AIDS 2015

43/54

4hat can be done in thewor$places;

The wor$place can help

limit the spreadand alle+iate the

impact of IV and "I#S%

Enterprises can respond to the

8/9/2019 001-HIV AIDS 2015

44/54

7% Thro)gh polic. de+elopment g)ided b.e'isting labor laws and standards

/" 0123 and the National4or$place 5olic.

8/9/2019 001-HIV AIDS 2015

45/54

hat com.anies need to do

C 3reate company policy on HIV and

I* prevention

C olicy to !e disseminated to all

worBers

8/9/2019 001-HIV AIDS 2015

46/54

C rovide information and edcation, trainin" if

needed

E what is HIV and I* E what are the effects of HIV and I* to the person

as a worBer, to the company, to the commnity

E how it can !e prevented

E what are the availa!le services&within

and otside of the company

hat com.anies need to do

8/9/2019 001-HIV AIDS 2015

47/54

8/9/2019 001-HIV AIDS 2015

48/54

?I8* & OJG

C -om.anies =ith HIV and AIDSPolic" and Poams

3,38

B)rea) of >abor Statistics & Integrated S)r+e.Non "gric)lt)ral Establishments Emplo.ing

8/9/2019 001-HIV AIDS 2015

49/54

1 1W'r+plae In*er-en*!'n) 'n

HIV an AIDS Pre-en*!'n

• W2a* '%pan!e) are '!n1& information and ed)cation

?participants became IV and "I#Sed)cators@

& Nondiscriminator. polic. statements

& Integration of IV polic. in their OS polic.and program

& Corporate social responsibilit. acti+ities

D'$%en*!n1 Pr'1ra%):

8/9/2019 001-HIV AIDS 2015

50/54

C'%pan!e) rep'r*e *2e ('ll'!n1pr'&le%) !n *2e!r p'l! an pr'1ra%

!%ple%en*a*!'n:

• >ac$ of management and wor$er s)pport

• >ac$ of technical capabilit. to implementtheir policies and programs

• 6ocal persons ha+e other f)nctions• STI* IV and "I#S disc)ssions not well

accepted b. both management and wor$ers

1 1W'r+plae In*er-en*!'n) 'n

HIV an AIDS Pre-en*!'n

8/9/2019 001-HIV AIDS 2015

51/54

P'l! S*a*e%en*

Re)pe* *2e !n!-!$al r!12*) an!1n!* '( pe'ple !*2 HIV an AIDS

Pr'%'*e n'n4!)r!%!na*'re%pl'%en* re1arle)) '( HIV )*a*$),

1ener, )e@$al 'r!en*a*!'n En'$ra1e %a@!%$% par*!!pa*!'n '(

!*) e%pl'ee) !n HIV an AIDSe$a*!'n pr'1ra%

Sa%ple W'r+plae P'l! '( a P2!l!pp!ne C'%pan


8/9/2019 001-HIV AIDS 2015

52/54

P'l! )*a*e%en* 'n 'n*!n$e e%pl'%en*

“In order to manage employees’ HIV status moreeffectively, the company aims to assist employeeswho are HIV positive to remain well for as long as

possile. !mployees, however, need to ma"e a choiceas to whether they wish to carry on in the sameposition or accept a position which is less stressful.#his would e dependent on availaility of alternativepositions$.

“%hen an employees’ performance decreases, they wille treated e&uitaly and in a non'discriminatorymanner, resolving issues of sic" leave, pensionenefits and medical aid as for other employees witha life threatening disease$.


THE WA=

8/9/2019 001-HIV AIDS 2015

53/54

THE WA=FORWARD

C /=G/G=8 and O7KG7* shall @ointlydevelop HIV and I* policies to !e translatedinto pro"rams made Bnown to all worBers.

C ctions shold focs on how to stren"thenpreventive measres despite e>istin" limitations.

8/9/2019 001-HIV AIDS 2015

54/54

THA$J @6#)

001-HIV AIDS 2015

Documents

Transcript of 001-HIV AIDS 2015